PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,961 | -90.7% | 8,350 | -89.1% | 0.00% | -100.0% |
| Q1 2023 | $236,957 | -1.1% | 76,685 | +35.4% | 0.00% | 0.0% |
| Q4 2022 | $239,536 | +280.2% | 56,628 | +113.3% | 0.00% | – |
| Q3 2022 | $63,000 | -25.0% | 26,545 | -9.4% | 0.00% | -100.0% |
| Q2 2022 | $84,000 | -80.0% | 29,310 | -36.0% | 0.00% | -80.0% |
| Q2 2021 | $420,000 | +69.4% | 45,777 | +92.7% | 0.01% | +25.0% |
| Q2 2020 | $248,000 | – | 23,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 207,500 | $21,609,000 | 4.97% |
| WEATHERBIE CAPITAL, LLC | 250,296 | $26,066,000 | 2.47% |
| Redmile Group, LLC | 172,092 | $17,922,000 | 2.14% |
| Tekla Capital Management LLC | 185,820 | $19,351,000 | 1.93% |
| Iguana Healthcare Management, LLC | 35,000 | $3,645,000 | 1.68% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $592,210,000 | 1.62% |
| Atika Capital Management LLC | 11,350 | $1,182,000 | 1.01% |
| Eventide Asset Management | 44,900 | $4,676,000 | 0.73% |
| Ghost Tree Capital, LLC | 11,330 | $1,180,000 | 0.70% |
| BB BIOTECH AG | 117,991 | $12,288,000 | 0.63% |